Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria

被引:0
作者
Antonia C. Kastoris
Petros I. Rafailidis
Evridiki K. Vouloumanou
Ioannis D. Gkegkes
Matthew E. Falagas
机构
[1] Alfa Institute of Biomedical Sciences (AIBS),Department of Medicine
[2] Henry Dunant Hospital,Department of Medicine
[3] Tufts University School of Medicine,undefined
[4] Alfa Institute of Biomedical Sciences (AIBS),undefined
来源
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词
Drug-resistance; Synergistic combinations; Antagonism; MRSA; ESBLs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:359 / 368
页数:9
相关论文
共 248 条
[1]  
Falagas ME(2008)Potential of old-generation antibiotics to address current need for new antibiotics Expert Rev Anti Infect Ther 6 593-600
[2]  
Grammatikos AP(2005)Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infect Dis 40 1333-1341
[3]  
Michalopoulos A(2008)Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in the Netherlands? J Antimicrob Chemother 62 356-359
[4]  
Falagas ME(1997)Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections Drugs 53 637-656
[5]  
Kasiakou SK(2008)Fosfomycin: use beyond urinary tract and gastrointestinal infections Clin Infect Dis 46 1069-1077
[6]  
Knottnerus BJ(2009)Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies Int J Antimicrob Agents 34 111-120
[7]  
Nys S(2009)Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases Antimicrob Agents Chemother 53 1278-1280
[8]  
Ter Riet G(2008)Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli Arch Intern Med 168 1897-1902
[9]  
Donker G(2007)Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa Chemotherapy 53 202-209
[10]  
Geerlings SE(2006)In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus Rev Esp Quimioter 19 252-257